Table 4 Obstetric and neonatal outcomes
Outcome | Testosterone | Placebo | Mean difference (95% CI) | P value | ||
|---|---|---|---|---|---|---|
na | na | |||||
Gestational age at delivery (weeks) | 14 | 37.8 ± 2.9 | 20 | 39.1 ± 1.6 | −1.26 (−2.82 to 0.28) | 0.11 |
Singleton | 11 | 38.6 ± 1.5 | 20 | 39.1 ± 1.6 | −0.49 (−1.66 to 0.68) | 0.40 |
Twin | 3 | 35.0 ± 4.7 | - | - | - | |
Birth weight (g)b | 18 | 2955 ± 789 | 19 | 3087 ± 438 | −131 (−555 to 291) | 0.53 |
Singleton | 12 | 3259 ± 483 | 19 | 3087 ± 438 | 172 (−172 to 516) | 0.31 |
Twin | 6 | 2348 ± 968 | - | - | - | |
Relative Risk (95% CI) | ||||||
Mode of delivery No. (%) | ||||||
Vaginal | 15 | 7 (46.7) | 20 | 9 (45.0) | 1.11 (0.54–2.26) | 0.77 |
CS | 15 | 7 (46.7) | 20 | 11 (55.0) | - | - |
Missing | 15 | 1 (6.7) | - | - | - | |
Congenital anomaly, No. (%)b | 18 | - | 20 | - | - | - |
Neonatal sex, No. (%)b | ||||||
Female | 18 | 9 (50.0) | 20 | 10 (50.0) | 1.00 (0.52–1.89) | 1.00 |
Male | 18 | 9 (50.0) | 20 | 10 (50.0) | - | - |